世界の皮膚科処方薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prescription Dermatology Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4760 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、皮膚科処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（真菌感染症薬、皮膚がん薬、にきび＆酒皶薬、乾癬薬、皮膚炎＆脂漏症薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・皮膚科処方薬の市場動向 ・企業の競争状況、市場シェア ・皮膚科処方薬の種類別市場規模と予測2016-2027（真菌感染症薬、皮膚がん薬、にきび＆酒皶薬、乾癬薬、皮膚炎＆脂漏症薬） ・皮膚科処方薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・皮膚科処方薬の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚科処方薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚科処方薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚科処方薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚科処方薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AbbVie、Johnson & Johnson、Novartis、Amgen、Eli Lilly、Celgene、LEO Pharma、Bausch Health Companies、Sun Pharmaceutical、Aclaris Therapeutics） ・結論

Based on product types,the psoriasis drugs segment dominated the global market prescription dermatology therapeutics in 2017.

Market Analysis and Insights: Global Prescription Dermatology Therapeutics Market
The global Prescription Dermatology Therapeutics market size is projected to reach US$ 40000 million by 2027, from US$ 26870 million in 2020, at a CAGR of 5.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Dermatology Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Dermatology Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Dermatology Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Dermatology Therapeutics market.

Global Prescription Dermatology Therapeutics Scope and Market Size
Prescription Dermatology Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prescription Dermatology Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fungal Infection Drugs
Skin Cancer Drugs
Acne & Rosacea Drugs
Psoriasis Drugs
Dermatitis & Seborrhea Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
AbbVie
Johnson & Johnson
Novartis
Amgen
Eli Lilly
Celgene
LEO Pharma
Bausch Health Companies
Sun Pharmaceutical
Aclaris Therapeutics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Dermatology Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fungal Infection Drugs
1.2.3 Skin Cancer Drugs
1.2.4 Acne & Rosacea Drugs
1.2.5 Psoriasis Drugs
1.2.6 Dermatitis & Seborrhea Drugs
1.3 Market by Application
1.3.1 Global Prescription Dermatology Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prescription Dermatology Therapeutics Market Perspective (2016-2027)
2.2 Prescription Dermatology Therapeutics Growth Trends by Regions
2.2.1 Prescription Dermatology Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prescription Dermatology Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Prescription Dermatology Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Prescription Dermatology Therapeutics Industry Dynamic
2.3.1 Prescription Dermatology Therapeutics Market Trends
2.3.2 Prescription Dermatology Therapeutics Market Drivers
2.3.3 Prescription Dermatology Therapeutics Market Challenges
2.3.4 Prescription Dermatology Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prescription Dermatology Therapeutics Players by Revenue
3.1.1 Global Top Prescription Dermatology Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Prescription Dermatology Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prescription Dermatology Therapeutics Revenue
3.4 Global Prescription Dermatology Therapeutics Market Concentration Ratio
3.4.1 Global Prescription Dermatology Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Dermatology Therapeutics Revenue in 2020
3.5 Prescription Dermatology Therapeutics Key Players Head office and Area Served
3.6 Key Players Prescription Dermatology Therapeutics Product Solution and Service
3.7 Date of Enter into Prescription Dermatology Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prescription Dermatology Therapeutics Breakdown Data by Type
4.1 Global Prescription Dermatology Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Prescription Dermatology Therapeutics Forecasted Market Size by Type (2022-2027)

5 Prescription Dermatology Therapeutics Breakdown Data by Application
5.1 Global Prescription Dermatology Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Prescription Dermatology Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prescription Dermatology Therapeutics Market Size (2016-2027)
6.2 North America Prescription Dermatology Therapeutics Market Size by Type
6.2.1 North America Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
6.3 North America Prescription Dermatology Therapeutics Market Size by Application
6.3.1 North America Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
6.4 North America Prescription Dermatology Therapeutics Market Size by Country
6.4.1 North America Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prescription Dermatology Therapeutics Market Size (2016-2027)
7.2 Europe Prescription Dermatology Therapeutics Market Size by Type
7.2.1 Europe Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
7.3 Europe Prescription Dermatology Therapeutics Market Size by Application
7.3.1 Europe Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
7.4 Europe Prescription Dermatology Therapeutics Market Size by Country
7.4.1 Europe Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type
8.2.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application
8.3.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region
8.4.1 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prescription Dermatology Therapeutics Market Size (2016-2027)
9.2 Latin America Prescription Dermatology Therapeutics Market Size by Type
9.2.1 Latin America Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Prescription Dermatology Therapeutics Market Size by Application
9.3.1 Latin America Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Prescription Dermatology Therapeutics Market Size by Country
9.4.1 Latin America Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type
10.2.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application
10.3.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country
10.4.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prescription Dermatology Therapeutics Introduction
11.1.4 Pfizer Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Prescription Dermatology Therapeutics Introduction
11.2.4 AbbVie Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Introduction
11.3.4 Johnson & Johnson Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Prescription Dermatology Therapeutics Introduction
11.4.4 Novartis Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Prescription Dermatology Therapeutics Introduction
11.5.4 Amgen Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Prescription Dermatology Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Celgene
11.7.1 Celgene Company Details
11.7.2 Celgene Business Overview
11.7.3 Celgene Prescription Dermatology Therapeutics Introduction
11.7.4 Celgene Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.7.5 Celgene Recent Development
11.8 LEO Pharma
11.8.1 LEO Pharma Company Details
11.8.2 LEO Pharma Business Overview
11.8.3 LEO Pharma Prescription Dermatology Therapeutics Introduction
11.8.4 LEO Pharma Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.8.5 LEO Pharma Recent Development
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Details
11.9.2 Bausch Health Companies Business Overview
11.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Introduction
11.9.4 Bausch Health Companies Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.9.5 Bausch Health Companies Recent Development
11.10 Sun Pharmaceutical
11.10.1 Sun Pharmaceutical Company Details
11.10.2 Sun Pharmaceutical Business Overview
11.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Introduction
11.10.4 Sun Pharmaceutical Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.10.5 Sun Pharmaceutical Recent Development
11.11 Aclaris Therapeutics
11.11.1 Aclaris Therapeutics Company Details
11.11.2 Aclaris Therapeutics Business Overview
11.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Introduction
11.11.4 Aclaris Therapeutics Revenue in Prescription Dermatology Therapeutics Business (2016-2021)
11.11.5 Aclaris Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prescription Dermatology Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fungal Infection Drugs
Table 3. Key Players of Skin Cancer Drugs
Table 4. Key Players of Acne & Rosacea Drugs
Table 5. Key Players of Psoriasis Drugs
Table 6. Key Players of Dermatitis & Seborrhea Drugs
Table 7. Global Prescription Dermatology Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prescription Dermatology Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Prescription Dermatology Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Prescription Dermatology Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Prescription Dermatology Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Prescription Dermatology Therapeutics Market Share by Regions (2022-2027)
Table 13. Prescription Dermatology Therapeutics Market Trends
Table 14. Prescription Dermatology Therapeutics Market Drivers
Table 15. Prescription Dermatology Therapeutics Market Challenges
Table 16. Prescription Dermatology Therapeutics Market Restraints
Table 17. Global Prescription Dermatology Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Prescription Dermatology Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Prescription Dermatology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatology Therapeutics as of 2020)
Table 20. Ranking of Global Top Prescription Dermatology Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Prescription Dermatology Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Prescription Dermatology Therapeutics Product Solution and Service
Table 24. Date of Enter into Prescription Dermatology Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Prescription Dermatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Prescription Dermatology Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Prescription Dermatology Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Prescription Dermatology Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Prescription Dermatology Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Prescription Dermatology Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Prescription Dermatology Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Prescription Dermatology Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Prescription Dermatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Prescription Dermatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Prescription Dermatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Prescription Dermatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Prescription Dermatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Prescription Dermatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Prescription Dermatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Prescription Dermatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Prescription Dermatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Prescription Dermatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Prescription Dermatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Prescription Dermatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Prescription Dermatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Prescription Dermatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Prescription Dermatology Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Prescription Dermatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Prescription Dermatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Prescription Dermatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Prescription Dermatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Prescription Dermatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Prescription Dermatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Prescription Dermatology Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Prescription Dermatology Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Prescription Dermatology Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Prescription Dermatology Therapeutics Product
Table 67. Pfizer Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. AbbVie Company Details
Table 70. AbbVie Business Overview
Table 71. AbbVie Prescription Dermatology Therapeutics Product
Table 72. AbbVie Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 73. AbbVie Recent Development
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Prescription Dermatology Therapeutics Product
Table 77. Johnson & Johnson Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Prescription Dermatology Therapeutics Product
Table 82. Novartis Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Amgen Company Details
Table 85. Amgen Business Overview
Table 86. Amgen Prescription Dermatology Therapeutics Product
Table 87. Amgen Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Amgen Recent Development
Table 89. Eli Lilly Company Details
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Prescription Dermatology Therapeutics Product
Table 92. Eli Lilly Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. Celgene Company Details
Table 95. Celgene Business Overview
Table 96. Celgene Prescription Dermatology Therapeutics Product
Table 97. Celgene Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Celgene Recent Development
Table 99. LEO Pharma Company Details
Table 100. LEO Pharma Business Overview
Table 101. LEO Pharma Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 102. LEO Pharma Recent Development
Table 103. Bausch Health Companies Company Details
Table 104. Bausch Health Companies Business Overview
Table 105. Bausch Health Companies Prescription Dermatology Therapeutics Product
Table 106. Bausch Health Companies Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Bausch Health Companies Recent Development
Table 108. Sun Pharmaceutical Company Details
Table 109. Sun Pharmaceutical Business Overview
Table 110. Sun Pharmaceutical Prescription Dermatology Therapeutics Product
Table 111. Sun Pharmaceutical Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Sun Pharmaceutical Recent Development
Table 113. Aclaris Therapeutics Company Details
Table 114. Aclaris Therapeutics Business Overview
Table 115. Aclaris Therapeutics Prescription Dermatology Therapeutics Product
Table 116. Aclaris Therapeutics Revenue in Prescription Dermatology Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Aclaris Therapeutics Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prescription Dermatology Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Fungal Infection Drugs Features
Figure 3. Skin Cancer Drugs Features
Figure 4. Acne & Rosacea Drugs Features
Figure 5. Psoriasis Drugs Features
Figure 6. Dermatitis & Seborrhea Drugs Features
Figure 7. Global Prescription Dermatology Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Prescription Dermatology Therapeutics Report Years Considered
Figure 12. Global Prescription Dermatology Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Prescription Dermatology Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Prescription Dermatology Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Prescription Dermatology Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Prescription Dermatology Therapeutics Market Share by Players in 2020
Figure 17. Global Top Prescription Dermatology Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatology Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Prescription Dermatology Therapeutics Revenue in 2020
Figure 19. Global Prescription Dermatology Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Prescription Dermatology Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Prescription Dermatology Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Prescription Dermatology Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Prescription Dermatology Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Prescription Dermatology Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Prescription Dermatology Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Prescription Dermatology Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Prescription Dermatology Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Prescription Dermatology Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Prescription Dermatology Therapeutics Market Share by Region (2016-2027)
Figure 41. China Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Prescription Dermatology Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Prescription Dermatology Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Prescription Dermatology Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Prescription Dermatology Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Prescription Dermatology Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Prescription Dermatology Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Prescription Dermatology Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 66. Celgene Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 67. LEO Pharma Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 68. Bausch Health Companies Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 69. Sun Pharmaceutical Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 70. Aclaris Therapeutics Revenue Growth Rate in Prescription Dermatology Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---